Gempharmatech Co. Ltd. A (688046) — Financial Flexibility Index

Latest as of December 2024: 0.47x

Gempharmatech Co. Ltd. A (688046) has a Financial Flexibility Index of 0.47x as of December 2024. Free cash flow of CN¥203.99 Million (operating CF CN¥90.31 Million minus capex CN¥113.68 Million) represents 0% of total liabilities (CN¥437.92 Million). Check financial resilience of Gempharmatech Co. Ltd. A to evaluate the company's liquid asset resilience ratio.

Financial Flexibility Index

0.47x
Free Cash Flow / Total Liabilities

Free Cash Flow

CN¥203.99 Million
Operating CF − Capex

Total Liabilities

CN¥437.92 Million
CNY

Capital Expenditures

CN¥113.68 Million
CNY

Gempharmatech Co. Ltd. A Financial Flexibility Index (2019–2024)

Historical Financial Flexibility Index trend for Gempharmatech Co. Ltd. A across 6 annual periods. See working capital position of Gempharmatech Co. Ltd. A to evaluate short-term liquidity relative to the company's equity base.

Annual Financial Flexibility Index for Gempharmatech Co. Ltd. A (2019–2024)

Year-by-year free cash flow to debt coverage for Gempharmatech Co. Ltd. A. For the full company profile including market capitalisation, see Gempharmatech Co. Ltd. A (688046) total market value.

Year Flexibility Index Free Cash Flow (CNY) Operating CF Total Liabilities YoY Change
2024 0.47x CN¥203.99 Million CN¥90.31 Million CN¥437.92 Million ▼ -34.6%
2023 0.71x CN¥322.47 Million CN¥116.57 Million CN¥452.93 Million ▼ -33.7%
2022 1.07x CN¥296.29 Million CN¥105.98 Million CN¥276.00 Million ▲ +42.6%
2021 0.75x CN¥202.39 Million CN¥113.31 Million CN¥268.78 Million ▼ -42.7%
2020 1.31x CN¥296.85 Million CN¥129.79 Million CN¥225.95 Million ▲ +75.1%
2019 0.75x CN¥110.78 Million CN¥65.12 Million CN¥147.66 Million
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities